PPHM - Peregrine Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Oct 2017)Next Qtr. (Jan 2018)Current Year (2018)Next Year (2019)
No. of Analysts1110
Avg. Estimate-0.12-0.12-0.440
Low Estimate-0.12-0.12-0.440
High Estimate-0.12-0.12-0.440
Year Ago EPS-0.14-0.28-0.88-0.44
Revenue EstimateCurrent Qtr. (Oct 2017)Next Qtr. (Jan 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate13.54M8.8M54.7M65.97M
Low Estimate13.54M8.8M54.7M65.97M
High Estimate13.54M8.8M54.7M65.97M
Year Ago Sales23.37M10.75M57.63M54.7M
Sales Growth (year/est)-42.10%-18.10%-5.10%20.60%
Earnings History10/30/20161/30/20174/29/20177/30/2017
EPS Est.-0.19-0.21-0.07-0.12
EPS Actual-0.14-0.28-0.16-0.06
Difference0.05-0.07-0.090.06
Surprise %26.30%-33.30%-128.60%50.00%
EPS TrendCurrent Qtr. (Oct 2017)Next Qtr. (Jan 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.12-0.12-0.440
7 Days Ago-0.12-0.12-0.44-0.07
30 Days Ago-0.08-0.12-0.4-0.07
60 Days Ago-0.08-0.12-0.4-0.07
90 Days Ago00-0.35-0.07
EPS RevisionsCurrent Qtr. (Oct 2017)Next Qtr. (Jan 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesPPHMIndustrySectorS&P 500
Current Qtr.14.30%N/AN/A0.16
Next Qtr.57.10%N/AN/A0.27
Current Year50.00%N/AN/A0.07
Next YearN/AN/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A